BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT
BridgeBio Oncology Therapeutics, Inc. shareholders
As of Sep 30, 2026, 87 institutions reported holding BridgeBio Oncology Therapeutics, Inc., 75.1% of its shares. Largest: Cormorant Asset Management, LP, BlackRock and Omega Fund Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of BridgeBio Oncology Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 17.9M | 22.3% | no change | Nov 16, 2026 |
| BlackRock | 4.01M | 5.0% | +1.86M | Nov 13, 2026 |
| Omega Fund Management, LLC | 3.29M | 4.1% | no change | Nov 16, 2026 |
| Deerfield Management Company, L.P. | 3.14M | 3.9% | −1.75M | Nov 16, 2026 |
| Alphabet Inc. | 2.82M | 3.5% | no change | Nov 5, 2026 |
| Citadel | 2.7M | 3.4% | +79,250 | Nov 16, 2026 |
| Enavate Sciences Gp, LLC | 2.63M | 3.3% | no change | Nov 16, 2026 |
| Regents Of The University Of California | 2.51M | 3.1% | new | Oct 26, 2026 |
| Vanguard | 2.27M | 2.8% | −41,728 | Nov 13, 2026 |
| Armistice Capital, LLC | 2.26M | 2.8% | +500K | Nov 16, 2026 |